Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+47.6%
5Y CAGR+55.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+47.6%/yr
vs -0.7%/yr prior
5Y CAGR
+55.1%/yr
Recent deceleration
Acceleration
+48.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
9x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$169.41M+53.2%
2024$110.61M+43.5%
2023$77.06M+46.2%
2022$52.73M+152.0%
2021$20.92M+10.7%
2020$18.90M-43.0%
2019$33.18M-38.9%
2018$54.27M+62.6%
2017$33.37M-3.2%
2016$34.47M-